Recruiting

Diabetes Education

Sponsor:

Scripps Whittier Diabetes Institute

Code:

NCT06296550

Conditions

Diabetes Type 2

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Dulce Digital Text Messaging Intervention

CGM Device

Study Details

Brief summary:

The current research study will add continuous glucose monitoring devices to the evidence-based text messaging diabetes education program for patients with type 2 diabetes for 6 months. Results on the effectiveness of this intervention will be compared for non-insulin using patients.

Conditions

Diabetes Type 2

Study ID

NCT06296550

Start date

Apr 3, 2025

Status verified date

Mar, 2026

Completion date

Apr 30, 2027

Anticipated

Primary completion date

Apr 30, 2027

Anticipated

Eligibility Criteria

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Inclusion Criteria:

  • Diagnosed with type 2 diabetes
  • Are not currently using a CGM
  • Are not using insulin therapies
  • Speak English, Spanish or Arabic
  • Have A1c between 7.5% and 12.0% in last 90 days
  • Have a cellphone that can receive/send text messages and counts steps

Exclusion Criteria:

  • Are using insulin therapies
  • Are pregnant
  • Are currently using a CGM
  • Are currently participating in another diabetes-related study

Study Design

Enrollment

140 participants

Anticipated

Allocation

Randomized

Intervention Model

Parallel Assignment

Primary purpose

Supportive Care

Interventions and Outcome Measures

Arms

experimental: CGM Group

Participants will be provided continuous glucose monitors (Dexcom G7) to monitor blood glucose for the entire duration of this study (i.e., one new device every 10 days for a total of 18 devices to last up to 6 months).

other: Usual Care Blood Glucose Monitoring Group

Participants will use standard blood glucose monitoring devices that are covered by health insurance.

Interventions

Dulce Digital Text Messaging Intervention

Text-based education support program:

  • Participants will receive text messages about diabetes and how to take care of diabetes and health. Participants will receive 2-3 messages every day for first 3 months, and then will slowly decrease over the last 3-months.
  • Participants will also receive text messages that will ask them to test their blood sugar and text back blood sugar reading.

CGM Device

Participants will be provided continuous glucose monitors (Dexcom G7) to actively monitor blood glucose for the entire duration of this study (i.e., one new device every 10 days for a total of 18 devices to last up to 6 months). In addition, participants will attend an information session (group or individual; in-person or virtual) that will provide instructions on using continuous glucose monitors.

Primary outcome measure

  • HbA1c [ Time Frame: 6 months ]

Central Contacts and Locations

Central contacts

Kallie Brown, PhD

858-258-3555brown.kallie@scrippshealth.org

Athena Philis-Tsimikas, MD

877-944-8843philis-Tsimikas.athena@scrippshealth.org

Locations

Scripps Whittier Diabetes Institute

Recruiting

San Diego, California, United States, 92037

Contacts

Athena Philis-Tsimikas, MD

877-944-8843tsimikas.athena@scrippshealth.org

Kallie Brown, PhD

858-258-3555brown.kallie@scrippshealth.org

More Information

Sponsor

Scripps Whittier Diabetes Institute

Last update posted

Mar 6, 2026

Last verified

Mar, 2026

Keywords

  • Diabetes
  • CGM
  • Diabetes Education

Trial information was received from ClinicalTrials.gov and was last updated on 2026-09-10. This information was provided to ClinicalTrials.gov by Scripps Whittier Diabetes Institute on 2026-03-06.